Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 70Neoplasm Metastasis 11Prostatic Neoplasms 9Pain 8Osteoporosis 8Multiple Myeloma 5Humoral Hypercalcemia Of Malignancy 4Triple Negative Breast Neoplasms 3Bone Diseases, Metabolic 3Neoplasms 2Lung Neoplasms 2Breast Neoplasms, Male 2Bone Neoplasms 2Bone Diseases 2Renal Insufficiency 1Ovarian Neoplasms 1Neovascularization, Pathologic 1Neoplastic Cells, Circulating 1Neoplasms by Site 1Neoplasm Micrometastasis 1Metastatic Breast Cancer With Bone Involvement 1Hereditary Breast and Ovarian Cancer Syndrome 1Fractures, Bone 1Fatigue 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Diseases 1Breast Cancer Metastatic 1

Interventions

Zoledronic Acid 1Trastuzumab 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Epirubicin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Micrometastasis × Zoledronic Acid × Breast × Clear all
NCT00242203 2013-08-13

Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer

Washington University School of Medicine

Phase 2 Completed
120 enrolled
Breast

Breast Neoplasms, Neoplasm Micrometastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡